JAN (NYSE:JAN) Research Coverage Started at Huntington

Huntington started coverage on shares of JAN (NYSE:JAN) in a report issued on Thursday morning, Marketbeat.com reports. The firm issued an outperform rating and a $36.00 price objective on the stock.

Several other analysts have also commented on the company. Royal Bank Of Canada increased their price objective on JAN from $30.00 to $34.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Barclays boosted their target price on JAN from $33.00 to $34.00 and gave the stock an “overweight” rating in a research note on Monday, August 31st. Zacks Research lowered JAN from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Morgan Stanley raised their price target on JAN from $28.00 to $31.00 and gave the stock an “overweight” rating in a report on Tuesday, August 18th. Finally, KeyCorp boosted their price target on JAN from $28.00 to $29.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 10th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, JAN presently has a consensus rating of “Moderate Buy” and an average target price of $31.71.

JAN Trading Up 0.3%

Shares of JAN stock opened at $30.91 on Thursday. The stock has a 50 day moving average price of $30.38. JAN has a 52-week low of $22.76 and a 52-week high of $32.83.

JAN (NYSE:JAN) last posted its earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.18). The company had revenue of $216.46 million for the quarter, compared to the consensus estimate of $203.32 million. JAN’s revenue was up 45.4% on a year-over-year basis. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. On average, equities research analysts expect that JAN will post 0.97 earnings per share for the current fiscal year.

JAN Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Friday, September 11th will be given a dividend of $0.0475 per share. The ex-dividend date of this dividend is Friday, September 11th. This represents a c) dividend on an annualized basis and a yield of 1.8%.

Institutional Trading of JAN

Large investors have recently made changes to their positions in the business. Engineers Gate Manager LP purchased a new position in shares of JAN during the second quarter worth $15,274,000. Readystate Asset Management LP acquired a new position in JAN during the second quarter valued at $1,724,000. WINTON GROUP Ltd purchased a new stake in JAN in the second quarter valued at $2,985,000. Wellington Management Group LLP purchased a new stake in JAN in the second quarter valued at $8,739,000. Finally, Greenland Capital Management LP acquired a new stake in JAN during the 2nd quarter worth about $575,000. 6.27% of the stock is owned by hedge funds and other institutional investors.

JAN News Roundup

Here are the key news stories impacting JAN this week:

• Positive Sentiment: Huntington initiated coverage of JAN with an “Outperform” rating and a $36 price target, implying approximately 17% upside from the reported reference price of $30.76. The new bullish coverage may improve investor sentiment and broaden institutional awareness of the stock. Huntington initiates JAN coverage
• Positive Sentiment: The company’s latest reported quarter showed revenue of $216.5 million, up 45.4% year over year and above analyst expectations of $203.3 million. Management also provided fiscal 2026 EPS guidance of $0.95 to $0.98, broadly consistent with the analyst consensus of $0.97.
• Neutral Sentiment: JAN previously reported quarterly EPS of $0.05, below the $0.23 consensus estimate. The earnings miss remains a risk, although strong revenue growth and the reaffirmed full-year outlook may be cushioning its impact.
• Neutral Sentiment: Recent JAN-related articles about JAN-PRO cleaning standards and the consumer software application “Jan” do not appear to provide material new information about the publicly traded company and are unlikely to be significant stock catalysts.

JAN Company Profile

JanOne Inc is a technology and life sciences company focused on addressing the global opioid crisis. The company’s activities include developing and supporting pharmaceutical and other solutions intended to help reduce opioid-related deaths and dependency.

JanOne has also pursued blockchain and financial technology initiatives through its Alt 5 Sigma operations. These activities have included blockchain-based payment, digital asset and financial services solutions designed to help businesses manage transactions and related digital assets.

The company serves markets through its healthcare, technology and financial services initiatives, with an emphasis on solutions that can be applied internationally.